Emergent BioSolutions Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of EBS for the last quarter is 293.80 M USD, and it's 15.35% higher compared to the previous quarter. The net income of Q3 24 is 114.80 M USD.